Differential processing of influenza nucleoprotein in human and mouse cells

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 625-635

  Braud, Veronique M ^a   McMichael, Andrew J ^a   Cerundolo, Vincenzo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Antigen presentation; Antigen processing; MHC; Proteasome

Indexed keywords

HLA A3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOPROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; HUMAN; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; ENDOPLASMIC RETICULUM; EPITOPES; HLA-A3 ANTIGEN; HUMANS; INFLUENZA A VIRUS; L CELLS (CELL LINE); MAST-CELL SARCOMA; MICE; NUCLEOPROTEINS; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL CORE PROTEINS;

EID: 0031911127     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<625::AID-IMMU625>3.0.CO;2-I     Document Type: Article

References (48)

1. Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R. and Wiley, D. C., Identification of self peptides bound to purified HLA-B27. Nature 1991. 353: 326-329 .
2. Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E. and Engelhard, V. H., Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263.
3. Groettrup, M., Soza, A., Kuckelkorn, U. and Kloetzel, P., Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 1996. 17: 429-435.
4. Lowe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W. and Huber, R., Crystal structure of the 20 S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science 1995. 268: 533-539.
5. Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. D. and Huber, R., Structure of 20 S proteasome from yeast at 2.4 A resolution. Nature 1997. 386: 463-471.
6. Seemuller, E., Lupas, A., Stock, D., Lowe, J., Huber, R. and Baumeister, W., Proteasome from Thermoplasma acidophilum: a threonine protease. Science 1995. 268: 579-582.
7. Schmidtke, G., Kraft, R., Kostka, S., Henklein, P., Frommel, C., Lowe, J., Huber, R., Kloetzel, P. M. and Schmidt, M., Analysis of mammalian 20 S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J. 1996. 15: 6887-6898.
8. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J. and Schreiber, S. L., Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995. 268: 726-731.
9. Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L. and Rock, K. L., Lactacystin and clasto-lactacystinβ-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility class I antigen presentation. J. Biol. Chem. 1997. 272: 13437-13445.
10. Cerundolo, V., Benham, A., Braud, V., Mukherjee, S., Gould, K., Macino, B., Neefjes, J. and Townsend, A., The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 1997. 27: 336-341.
11. Van Kaer, L., Ashton Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K. L., Goldberg, A. L., Doherty, P. C. and Tonegawa, S., Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994. 1: 533-541.
12. Fehling, H. J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U. and von Boehmer, H., MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994. 265: 1234-1237.
13. Cerundolo, V., Kelly, A., Elliott, T., Trowsdale, J. and Townsend, A., Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 1995. 25: 554-562.
14. Sibille, C., Gould, K. G., Willard Gallo, K., Thomson, S., Rivett, A. J., Powis, S., Butcher, G. W. and De Baetselier, P., LMP2+ proteasomes are required for the presentation specific antigens to cytotoxic T lymphocytes. Curr. Biol. 1995. 5: 923-930.
15. Niedermann, G., Butz, S., Ihlenfeldt, H. G., Grimm, R., Lucchiari, M., Hoschutzky, H., Jung, G., Maier, B. and Eichmann, K., Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995. 2: 289-299.
16. Svensson, K., Levy, F., Sundberg, U., Boman, H., Hendil, K. B. and Kvist, S., Proteasomes generate in vitro a natural peptide of influenza-A nucleoprotein functional in HLA-B27 antigen assembly. Int. Immunol. 1996. 8: 467-478.
17. Ossendorp, F., Eggers, M., Neisig, A., Ruppert, T., Groettrup, M., Sijts, A., Mengede, E., Kloetzel, P., Neefjes, J., Koszinowski, U. and Melief, C., A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 1996. 5: 115-124.
18. Vinitsky, A., Anton, L. C., Snyder, H. L., Orlowski, M., Bennink, J. R. and Yewdell, J. W., A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. J. Immunol. 1997. 159: 554-564.
19. Powis, S. J., Deverson, E. V., Coadwell, W. J., Ciruela, A., Huskisson, N. S., Smith, H., Butcher, G. W. and Howard, J. C., Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992. 357: 211-215.
20. Heemels, M. and Ploegh, H. L., Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1994. 1: 775-784.
21. Schumacher, T. N., Kantesaria, D. V., Heemels, M. T., Ashton Rickardt, P. G., Shepherd, J. C., Fruh, K., Yang, Y., Peterson, P. A., Tonegawa, S. and Ploegh, H. L., Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator J. Exp. Med. 1994. 179: 533-540.
22. Momburg, F., Roelse, J., Howard, J. C., Butcher, G. W., Hämmerling, G. J. and Neefjes, J. J., Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994. 367: 648-651.
23. Falk, K., Rotzschke, O. and Rammensee, H., Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990. 348: 248-251.
24. Cerundolo, V., Elliott, T., Elvin, J., Bastin, J., Rammensee, H. G. and Townsend, A., The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur. J. Immunol. 1991. 21: 2069-2075.
25. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., del Guercio, M., Southwood, S., Kubo, R. T.,Chesnut, R. W., Grey, H. M. and Chisari, F. V., The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 1994. 153: 5585-5592.
26. Levitsky, V., Zhang, Q., Levitskaya, J. and Masucci, M. G., The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 1996. 183: 915-926.
27. van der Burg, S. H., Visseren, M. J. W., Brandt, R. M. P., Kast W. M. and Melief, C. J. M., Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996. 156: 3308-3314.
28. Sijts, A. J. A. M. and Pamer, E. G., Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J. Exp. Med. 1997. 185: 1403-1411.
29. DiBrino, M., Tsuchida, T., Turner, R. V., Parker, K. C., Coligan, J. E. and Biddison, W. E., T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 1993. 151: 5930-5935.
30. + cytotoxic T lymphocytes. Eur. J. Immunol. 1993. 23: 418-424.
31. Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. and Smith, G., Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 1988. 168: 1211-1224.
32. Neefjes, J. J., Momburg, F. and Hämmerling, G. J., Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993. 261: 769-771.
33. Christinck, E. R., Luscher, M. A., Barber, B. H. and Williams, D. B., Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 1991. 352: 67-70.
34. Neisig, A., Roelse, J., Sijts, A. J., Ossendorn, F., Feltkamp, M. C., Kast, W. M., Melief, C. J. and Neefjes, J. J., Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 1995. 154: 1273-1279.
35. Androlewicz, M. J., Anderson, K. S. and Cresswell, P., Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA 1993. 90: 9130-9134.
36. Villanueva, M. S., Fischer, P., Feen, K. and Pamer, E. G., Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1994. 1: 479-489.
37. Anton, L. C., Yewdell, J. W. and Bennink, J. R., MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 1997. 158: 2535-2542.
38. Driscoll, J., Brown, M. G., Finley, D. and Monaco, J. J., MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993. 365: 262-264.
39. Gaczynska, M., Rock, K. L. and Goldberg, A. L., Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993. 365: 264-267.
40. Kievits, F., Ivanyi, P., Krimpenfort, P., Berns, A. and Ploegh, H. L., HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 1987. 329: 447-449.
41. Arnold, B. and Hämmerling, G. J., MHC class-I transgenic mice. Annu Rev. Immunol. 1991. 9: 297-322.
42. Man, S., Newberg, M. H., Crotzer, V. L., Luckey, C. J., Williams, N. S., Chen, Y., Huczko, E. L., Ridge, J. P. and Engelhardt, V. H., Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. Int. Immunol. 1995. 7: 597-605.
43. Berger, A. E., Davis, J. E. and Cresswell, P., Monoclonal antibody to HLA-A3. Hybridoma 1982. 1: 87-90.
44. Sanchez Madrid, F., Krensky, A. M., Ware, C. F., Robbins, E., Strominger, J. L., Burakoff, S. J. and Springer, T. A., Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci. USA 1982. 79: 7489-7493.
45. Elliott, T., Willis, A., Cerundolo, V. and Townsend, A., Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 1995. 181: 1481-1491.
46. Nixon, D. F., Townsend, A. R., Elvin, J. G., Rizza, C. R., Gallwey, J. and McMichael, A. J., HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988. 336: 484-487.
47. Russ, G., Esquivel, F., Yewdell, J. W., Cresswell, P., Spies, T. and Bennick, J. R., Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. J. Biol. Chem. 1995. 270: 21312-21318.
48. Gotch, F., Rothbard, J., Howland, K., Townsend, A. and McMichael, A., Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987. 326: 881-882.